Literature DB >> 25726049

Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma.

Caitlin A McIntyre1, Jordan M Winter2.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) frequently presents at an advanced and incurable stage of the disease. Common signs and symptoms of PDA include abdominal or back pain, jaundice, weight loss, pruritus, and nausea/vomiting. Diagnostic workup includes serum chemistries and CA19-9, primarily to monitor disease status and response to treatment. Imaging studies are performed to assess resectability and stage disease, and pancreatic protocol computed tomography (CT) scan or magnetic resonance imaging (MRI) are the preferred imaging studies for this purpose. Conventional staging is based on the American Joint Cancer Committee (AJCC) Staging System, 7th Edition and informs prognosis, while surgical staging systems focus specifically on assessing the likelihood of a complete (negative margins) resection with operative management. Herein, we review the presenting signs and symptoms, the diagnostic evaluation, and staging of PDA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25726049     DOI: 10.1053/j.seminoncol.2014.12.003

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

1.  Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation.

Authors:  Douglas S Swords; Mary C Mone; Chong Zhang; Angela P Presson; Sean J Mulvihill; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

2.  Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.

Authors:  Derek P Logsdon; Michelle Grimard; Meihua Luo; Safi Shahda; Yanlin Jiang; Yan Tong; Zhangsheng Yu; Nicholas Zyromski; Ernestina Schipani; Fabrizio Carta; Claudiu T Supuran; Murray Korc; Mircea Ivan; Mark R Kelley; Melissa L Fishel
Journal:  Mol Cancer Ther       Date:  2016-08-17       Impact factor: 6.261

Review 3.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

4.  Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?

Authors:  Mengyu Feng; Zhe Cao; Zhiwei Sun; Taiping Zhang; Yupei Zhao
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

5.  Pancreatic cancer: Current status and Challenges.

Authors:  Amanda R Muñoz; Divya Chakravarthy; Jingjing Gong; Glenn A Halff; Rita Ghosh; Addanki P Kumar
Journal:  Curr Pharmacol Rep       Date:  2017-10-11

6.  High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.

Authors:  Yanmiao Huo; Minwei Yang; Wei Liu; Jianyu Yang; Xueliang Fu; Dejun Liu; Jiao Li; Junfeng Zhang; Rong Hua; Yongwei Sun
Journal:  J Exp Clin Cancer Res       Date:  2015-08-22

7.  SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).

Authors:  R Vera; E Dotor; J Feliu; E González; B Laquente; T Macarulla; E Martínez; J Maurel; M Salgado; J L Manzano
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

8.  Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.

Authors:  S Saman; M J Stagno; S W Warmann; N P Malek; R R Plentz; E Schmid
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

9.  A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.

Authors:  Li Yan; Yong-Liang Chen; Ming Su; Tian Liu; Kai Xu; Feng Liang; Wan-Qing Gu; Shi-Chun Lu
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

10.  Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.

Authors:  Jiyoung Park; Yonghwan Choi; Junghyun Namkung; Sung Gon Yi; Hyunsoo Kim; Jiyoung Yu; Yongkang Kim; Min-Seok Kwon; Wooil Kwon; Do-Youn Oh; Sun-Whe Kim; Seung-Yong Jeong; Wonshik Han; Kyu Eun Lee; Jin Seok Heo; Joon Oh Park; Joo Kyung Park; Song Cheol Kim; Chang Moo Kang; Woo Jin Lee; Seungyeoun Lee; Sangjo Han; Taesung Park; Jin-Young Jang; Youngsoo Kim
Journal:  Oncotarget       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.